Objective: the outcomes for patients after endovascular treatment of abdominal aortic aneurysm (AAA) are determined primarily by the endpoints of death and endoleaks, the latter representing continued risk of rupture. The data of a multicentre registry were analysed with regard to the early outcome of stent-graft procedures for AAA and the complications associated with this treatment. In addition, the results during follow-up were analysed by determining mortality and endoleak development as separate endpoints and as a combined endpoint defined as endoleak-free survival. Setting: 38 European institutions of Vascular Surgery collaborating in a multicentre registry project. Patients and methods: 899 patients with AAA underwent between May 1994 and March 1998 elective endovascular repair (818 men and 81 women; mean age 69 years). 80 (8.9%) of the patients had medical conditions that excluded them from open repair. 818 (91%) of patients had a bifurcated device, 63 (7%) had a straight tube graft, and only 18 (2%) had an aorto-uni-iliac device. Clinical examination and contrast-enhanced computed tomography was performed at fixed follow-up intervals to assess increase or decrease of the maximum transverse diameter (MTD). Endoleaks observed at follow-up were discriminated into persistent endoleak and temporary endoleak. The latter is defined as single time observed endoleaks or with two or more negative imaging studies between observed endoleaks. Life-table analyses were used to calculate the rates of freedom-from-endoleak (no endoleak at any time), freedom-from-persistent endoleak (no persistent endoleak), patient survival, and persistent-endoleak-free-survival. Results: the median follow-up of this patient series was 6.2 months. The ratio between observed and expected follow-up data was 82% for the overall follow-up period. However, at 18 months of follow-up this rate was only 45%. The number of patients followed during this period was sufficient to allow statistically meaningful assessment. The MTD in patients with temporary endoleaks demonstrated a significant decrease at 6 to 12 months compared to preoperative values (mean 57 and 53 respectively, p=0.004). In patients with persistent endoleaks there was no change between the preoperative and 6-month MTD (mean 57 and 60 mm respectively). At 6 and 18 months freedom-from-endoleak was 83% and 74% and freedom-from-persistent endoleak was 93% and 90%, respectively. The 18-month cumulative patient survival was 88% and the main outcome measure, the persistent endoleak-free-survival was 79%. Conclusions: the MTD decreases in patients with temporary endoleak, but not in patients with persistent endoleak. Therefore, the use of the rate of freedom-from-persistent endoleak, reflecting absence of persisting endoleaks to estimate the prognosis with regard to the AAA, is justified. Determining persistent endoleak-free survival appears a rational approach to provide a realistic outlook for patients with stent-grafted AAA. The observed 18-month endoleak-free survival reflects a satisfactory mid-term result.
Introduction
Following the initial successful application of stentgraft treatment by Parodi et al. in 1991 the short-term efficacy of endovascular abdominal aortic aneurysm * Presented at the Twelth Annual Meeting of the European Society (AAA) repair has been documented in a number of for Vascular Surgery, Paris, 1-4 October, 1998. publications. 1-6 However, with regard to mid-and † Please address all correspondence to: J. Buth, Department of long-term success much uncertainty remains. Most Vascular Surgery, PO Box 1350, 5602 ZA Eindhoven, The Netherlands. studies dealing with the outcome of endovascular 1078-5884/99/060507+10 $12.00/0 © 1999 W.B. Saunders Company Ltd. From the patient's perspective the possibility of ASA II 334 (37.1) dying, either from a related or unrelated cause, is of ASA III 408 (45.4) greatest relevance. Therefore, survival rate over time ASA IV 80 (8.9) is the principal risk to be assessed for the patient. But * Society of Vascular Surgery-International Society of Cardioendoleaks are also important. If an endoleak persists, vascular Surgery, North American Chapter.
the aneurysm remains at risk of rupture. Like survival, the absence of endoleak is a time-dependent outcome that may best be represented in a life-table format as notified to the EUROSTAR Data Registry Center prior rate of freedom-from-endoleak. Moreover, one may to operation. Data on patients operated upon before distinguish between freedom-from-endoleak for abthe 1st July 1996 were retrieved from hospital notes sence of any endoleak, and freedom-from-persistent and other records retrospectively. This cohort, which endoleak if only a persistent endoleak is the event of consisted of 364 patients, was treated in 19 centres. interest. Considering mortality and persistent en-Therefore, this study involved the data on a total of doleak as a combined endpoint, defined as "persistent-899 patients. They were provided from 38 centres in endoleak-free survival" appears a simple and practical different European countries. Ten of the centres had approach to provide a realistic prognosis to a patient recruited less than five patients, 11 centres five to 15 of what can be expected if he or she chooses to undergo patients, 14 centres 16 to 50 patients, two centres 51 this form of treatment.
to 100 patients, and one centre more than 100 patients. This report documents the results of a multicentre Of the 899 patients 818 (91%) were men, and 81 registry, organised by the "EUROSTAR" collaborators' (9%) were women. The mean age was 69 years (range group, with regard to the procedural and follow-up 37 to 90). The American Society of Anaesthesiology data of patients treated by stent-graft techniques in (ASA) risk classification was used to represent the a large number of European vascular institutions. 7 patient's risk profile. The distribution in the different The early outcome and perioperative complications categories is represented in Table 1 . Factors that may are outlined. In addition, with regard to the followhave influenced the decision to perform endovascular up period, freedom-from-endoleak, freedom-fromtreatment rather than an open surgical procedure inpersistent endoleak, patient survival and persistent cluded marked obesity in 192 patients (21%), previous endoleak-free survival rates are assessed. Because laparotomy in 229 patients (25%), unfit to undergo an there is considerable variation with regard to the esopen abdominal aortic procedure in 77 (9%), and unfit timated rates of complications and endoleaks between to tolerate general anaesthesia in 26 (3%). different institutions, this large-scale study was per-Detailed preoperative imaging of the abdominal formed to provide a realistic appraisal of the outcome aorta and iliac arteries by contrast-enhanced computed of endovascular AAA repair in Europe. tomography (CT), and aortography was performed in 99% and 97% respectively. The median maximum transverse diameter (MTD) of the aneurysms treated Methods was 55 mm with an interquartile range (IQR) of 48 to 60. The median infrarenal neck diameter was 22 mm The study period extended from April 1994 to April 1998. Two periods of patient enrolment could be dis-(IQR 21 to 24), and the median neck length was of 25 mm (IQR 20 to 32). An anatomical classification had tinguished. 1 Five hundred and thirty-five patients operated upon after 1st July 1996 had their procedures been described previously. 7 In the study 17% of the patients demonstrated a type A morphology (normal-An intra-arterial DSA was scheduled at 1 month and 12 months. A duplex study was performed at the same sized aortic cuff at the bifurcation), 55% had a type B (normal common iliac arteries), 17% type C (partial times as CT-scanning until the 12-month follow-up visit. For this study combined use was made of findings aneurysmal common iliac arteries), 7% type D (proximal aneurysmal common iliac artery with small distal at CT, DSA and duplex assessments. If abnormalities were observed with one modality this was the recorded normal segment) and 5% had a type E (completely aneurysmal common iliac arteries). 97% of patients finding. The prime imaging parameters determined preoperatively and with each follow-up visit were: (1) had symmetrical morphology, and the others had iliac arteries of different anatomical categories at the two the maximum transverse diameter (MTD), and (2) the presence or absence of perigraft flow in the aneurysmal sides.
Commercially manufactured devices for stent-graft sac, i.e. endoleakage. Endoleaks were distinguished as early endoleak, that is an endoleak observed before treatment was used in the majority of patients in this series, but two patients had a device implanted that discharge, and endoleaks at follow-up, that is all endoleaks observed at 1 month imaging studies and/or on had been constructed by the physician. 8, 9 Most participating centres were assisted during their first series subsequent follow-up studies. Endoleaks at follow-up included residual early endoleaks that continued to of cases by a vascular surgeon or a radiologist who had pioneered this therapeutic approach, and had exist after 1 month, and those which arose de novo.
Endoleaks were also classified by site: proximal at-extensive experience acquired with the type of device used. Most commonly procedures were performed in tachment, midgraft level, distal attachment site, and those originating from side-branches. the operating room using mobile fluoroscopy equipment. Completion angiograms were performed to assess the procedural results. Vascular surgeons and radiologists usually worked together in teams. There Data analysis and study endpoints were differences between centres with regard to the use of systemic or regional heparinisation, the ap-All data were recorded on a computerised database. plication of coil embolisation of side-branches prior
Operative technical details, such as the type of anto stent-graft, and the preference for a unilateral or aesthesia, and the need for adjuvant procedures were bilateral common femoral artery exploration with recorded. In addition, information on the duration of arteriotomy for the implantation of bifurcated devices.
the procedure, duration of fluoroscopy, duration of intensive care unit (ICU) stay, and duration of hospital administration were entered. Early results were represented by the mortality at one month, and the oc-Data collection and assessment currence of systemic and local (arterial) complications. All continuous variables were expressed as median Standardised Case Record Forms were made available by the EUROSTAR organisation to participating in-values and interquartile ranges.
Results after discharge were recorded in terms of stitutions from July 1996. During the prospective study period the informed consent registration page was late complications, and the development of endoleaks during follow-up. Two patterns of endoleak at follow-faxed preoperatively to the Data Registry Centre. Completed forms with baseline and clinical data, sum-up were distinguished in this analysis according to the frequency and the time period of identification: marised information on the CT and angiographic findings, details of the stent-graft procedure, and ob-(1) persisting endoleaks, which were observed either on at least two subsequent follow-up visits or with one servations from the completion angiography were sent to the Data Registry Center after discharge of the negative study in between the two positive studies,
(2) temporary endoleaks, which were all other endoleaks, patient. Subsequently, follow-up forms with clinical and imaging data were submitted after each outpatient e.g. a single-time-observed leak, or more than one negative study between two positive studies, i.e. re-visit. Follow-up data consisted of information on the patient's general condition as well as the presence or mote occurrence.
Changes in the MTD of aneurysms between the absence of endoleaks and changes in the MTD of the aneurysmal sac. In the case of death or conversion to preoperative measurements and imaging examinations during follow-up were correlated with the oc-an open procedure details of these events were recorded as they occurred.
currence of endoleaks at follow-up. Median values and interquartile ranges were used to represent these The imaging follow-up protocol included a CT-scan at 1, 3, 6, 12, 18 and 24 months, and yearly thereafter. values. For this correlation a paired Wilcoxon test Failure to complete the implantation occurred in 26 patients. The reasons included migration, inability to was used. Life-table analysis and Kaplan-Meier curves deploy the device, inability to connect an iliac limb to were constructed to represent the freedom-from-endoleak a main device, and graft thrombosis. In 18, conversion (no endoleak at follow-up), freedom-from-persistent ento an open procedure was required. In five patients a doleak (no persistent endoleak at follow-up), and patient femorofemoral bypass was performed to bypass an survival. In addition, the cumulative survival and freeinadvertently caused iliac artery occlusion, and in dom-from-persistent endoleak data were combined three the procedure was abandoned. Early non-fatal into a persistent endoleak-free survival rate.
systemic complications occurred during hospital admission in 117 (13%) patients. The majority of these were cardiac in origin. Device-and procedure-related Results adverse events other than the need for conversion to an open procedure during or after the operation Devices and procedures occurred in 13% and access-site-related complications in another 13% (Table 3) . Of the 899 patients, 797 received a modular bifurcation device, 21 a uni-piece bifurcation device, 63 an aortoaortic straight tube stent-graft, and 18 an aorto-uniiliac device. In the last group the procedure included Early endoleak a femorofemoral crossover bypass, and stent occluder of one common iliac artery. The devices used were In 162 patients, 174 endoleaks were identified before Stentor⊂ (331 patients), Vanguard⊂ (455 patients), discharge. Of these, 39 were at the proximal attachment EVT⊂ (38 patients), Talent⊂ (63 patients), AneuRx⊂ (10 site, 29 at mid-graft level, 52 at the distal site (together patients), and physician-constructed prototype devices defined as graft-related endoleaks), and 54 consisted of (two patients). Seven hundred and twenty-eight (81%) backbleeding from side-branches (non-graft-related). procedures were performed under general an-Within 6 months 72 (41%) of the endoleaks had reaesthesia, 152 (17%) under spinal anaesthesia, and five solved spontaneously. Of the resolved endoleaks, 12 (0.6%) under local anaesthesia. In 14 patients the type were proximal, 15 mid-graft, 20 distal, and 25 sideof anaesthesia was not indicated. The median operbranch backbleeding. A secondary endovascular repair ation time was 140 min (106-210); the fluoroscopy time was undertaken in 12 patients, and an open procedure was 27 min ; the length of ICU stay was 21 h in one. Six patients had endoleaks at discharge that (18) (19) (20) (21) (22) (23) (24) ; and the duration of postprocedure hospital were related to failure to complete the stent-graft stay was 7 days (5-10). In 239 patients, 246 adjuvant procedure. Three of these underwent a conversion procedures were performed. One hundred and fiftywithin 6 months, and three patients were managed five patients had endovascular procedures and 84 conservatively. Fifty-four endoleaks persisted at 6 patients had open surgical procedures (Table 2) . months, 39 (32%) were graft-related and 15 (28%) were non-graft-related. This difference was not significant.
In 29 three by open repair at a later admission, four by visits, corrected for interval deaths was 82%. However, after 1 year there was a marked drop in this ratio to late endovascular repairs, and 12 endoleaks closed 45% at 18 months. spontaneously. Fifteen proximal endoleaks (38%, 15/ Adverse systemic events were observed after the 39), and 39 endoleaks at other sites (29%, 39/135) first postoperative month in 3 to 4% of patients in were still present after 6 months, rates that were not every 3 months' follow-up period. These complications significantly different.
included a wide range of conditions, usually not related to the procedure. Cardiovascular disease constituted 21 to 32% of events in each observation Complications at follow-up interval. Procedure or device-related complications The median follow-up period at the time of data occurred in 5 to 9% (Table 5 ). In six patients (0.7%) analysis was 6.2 months (range 0 to 48). This is inthe aneurysm ruptured during follow-up. In two of dicative of a high rate of patient recruitment during these the existence of an endoleak had been demthe most recent part of the study period. The comonstrated prior to rupture and one had a stent-graft pleteness of follow-up information is shown in Table infection. Further interventions for procedure and device-related complications were required during the 4. The overall ratio of observed to expected follow-up Table 6 , which were based on serial imaging. subsequent follow-up in 3 to 4.7% of the patients in based on the occurrence of persistent endoleaks only, was 90% (s.e. 2%) at 18 months of follow-up (Fig. 1) . each 3-month follow-up interval. Most of the interventions were by a transfemoral approach.
Aneurysm shrinkage
The median maximum transverse diameter (MTD) of Endoleak at follow-up the aneurysms in the overall group decreased significantly from a median preoperative value of 55 mm Endoleaks at follow-up developed in 1-5% in each (48-60) to 50 mm (42-58) at 6 to 12 months post-3-month follow-up interval (Table 6 ). Proximal endooperatively (p=0.0001). In patients who never had an leaks were relatively frequent during early follow-up, endoleak, there was a significant difference between but were not observed after the sixth postoperative the preoperative and 6-to 12-month values, 55 mm month. In contrast, endoleaks originating from the (48-60) and 49 mm (42-56) respectively (p=0.0001). In graft itself and distal endoleaks were noted throughout contrast, patients with persisting endoleaks had no the follow-up period up to 18 months postoperatively.
decrease of the median MTD, preoperatively 57 mm New endoleaks from lumbar arteries did not develop (50-65), and after 6-12 months 60 mm (54-63). Patients after 6 months. A total of 64 reinterventions (53 transwith temporary endoleaks demonstrated a significant femoral, 10 transabdominal and one crossover bypass drop in MTD, from 57 mm (54-63) to 53 mm (48-53) combined with an endovascular procedure) were per-(p=0.004). formed for endoleaks. Of these reinterventions were successful in resolving the endoleak.
The freedom-from-endoleak rate, representing the Survival and persistent endoleak-free survival absence of an endoleak at any time during follow-up, was 74% (s.e. 3%) at 18 months postoperatively. The Sixty patients died in the two years following the stent-graft procedure. In only two patients was rupture freedom-from-persistent endoleak rate, which was the registry after 1st July 1996, it was requested that of the aneurysm the cause of death. The cumulative they did not submit data on patients included in survival rate at 18 months was 88% (s.e. 2%). The their learning curve experience. Whilst differences in persistent endoleak-free survival, based on the comtreatment outcome may be influenced by the time bined patient survival and freedom-from-persistent period within the study that the operation took place, endoleak data was 79% (s.e. 2%) at 18 months (Fig. and experience of the team, this was not the subject 2).
of the present study. The main objective was to make a realistic assessment of results obtained from endovascular aneurysm repair in Europe today. The range Discussion of devices used represented all available stent-grafts during the study period. The predominance (89%) of This series represents the collective experience of 38 modular bifurcated grafts used was a reflection of the groups in European centres with stent-graft repair of important role played by European physicians in the AAA. Centres that were involved from the beginning development and early application of this type of of the registry had enrolled patients in the retrospective device. 10,11 Data collection in this large multicentre part of the study, and this included their early exseries was a laborious operation. The ratio between observed and expected data was acceptable perience with this technique. For centres that joined up to 12 months after operation, but declined to a early endoleaks were still present after 6 months, without much difference between graft-related and disappointing 40% at 18 months. Nevertheless, a meaningful analysis is possible.
non-graft-related endoleaks. Proximal endoleaks persisted just as frequently (38%, 15/39) as other endo-A rational indication for the treatment of an AAA, either by open or by endovascular surgery, may be leaks (29%, 39/135) until the sixth postoperative month. This finding corresponded with the ob-based on the premise that the mortality of treatment is less than the risk of rupture within one year. 12 The servations of Matsumura and Moore, who found no difference in the tendency of spontaneous closure early mortality of endovascular AAA-repair in recent studies varied from 0-6.6%. [6] [7] [8] [10] [11] [12] [13] [14] The few studies between proximal and other endoleaks. 21 Endoleaks were associated with device migration, graft throm-comparing patients treated with stent-grafts, with a contemporary group of controls treated by open sur-bosis, deployment problems or failure to connect the second iliac limb (inability to complete the procedure) gery, showed no difference in mortality. 15, 16 Our findings included an overall operative mortality in 899 in 4% of patients (6/162). The availability of adjunct device components, such as an extra short aortic cuff patients of 3.2%, and was significantly related to advanced co-morbidity. For ASA IV patients it was 12.8%. to seal the proximal attachment is essential.
Successful AAA exclusion results in a marked de-Parodi's series, consisting of patients with contraindications for open surgery, had a mortality of 8%. 17 crease in aneurysm size. The presence of endoleaks, on the other hand, may be associated with further It is to be expected that in series with predominantly low-risk patients the observed mortality will be sub-expansion of the aneurysm, and possibly rupture. [22] [23] [24] [25] [26] Proposals for the classification of endoleaks have been stantially lower. It follows that a meaningful comparison of open and endovascular AAA-repair should made by White et al. 19, 20 These authors distinguished primary endoleaks, existing from the initial procedure, preferably be made on the basis of a randomised study in which selection bias is accounted for. Until such a and secondary or late endoleaks, which develop de novo during follow-up. We found it difficult to follow study is completed choice of treatment must be based on personal preferences and economic factors. A lower precisely this classification, as it was impractical in a life-table analysis to distinguish residual procedural incidence of systemic complications, a shorter duration of hospital stay, and a more rapid recovery favour the endoleaks from endoleaks that develop after the perioperative period. Therefore endoleaks at follow-up, as endovascular procedure. But these advantages have to be contrasted with the expense of the stent-graft defined for the purpose of this study, included all endoleaks observed at 1 month or thereafter. Other and the necessity for long-term follow-up by imaging techniques because of the risk of late endoleak de-aspects of White's originally suggested definitions were applied in detail. We found that endoleaks ori-velopment.
Systemic complications were observed in the post-ginating from the graft and distal attachment sites continued to occur after 6 months of follow-up, operative period in 13%, cardiac, pulmonary, and renal dysfunction being most frequently encountered. This whereas new proximal attachment-site endoleaks and reinjection from side-branches were not observed after incidence is almost identical with the 14 to 17% as reported by Brewster and May, but higher than the this period.
Criteria for success have been outlined by the Ad 5% observed by Mialhe et al. 10, 15, 16 In comparison, the incidence of cardiac and pulmonary complications was Hoc Committee for Standardised Reporting Practices in Vascular Surgery of the Society for Vascular Sur-considerably lower in the present study than in a series of open operation reported in the Canadian Aneurysm gery/International Society for Cardiovascular Surgery. 27 This committee distinguished between technical Study (4% vs. 15%, and 3% vs. 8%, respectively). 18 This is in agreement with the observations of Brewster et success and clinical success for early postoperative results, and continuing success for late results. These al., who found, in a comparative study, a lower incidence of systemic complications in the stent-graft-definitions each encompass a range of variables including graft thrombosis, migration, infection and di-treated group. 16 Initial exclusion of the aneurysm was achieved in lation at or adjacent to the aneurysm as endpoints. In our view this approach will remain the basis for a 82% of this series (737/899). An 18% incidence of early endoleaks is in the middle of the reported range which methodological analysis of treatment results of endovascular AAA-repair. However, a patient-oriented ana-varies from 12-44%. 5, 10, 11, 14, 17, 19 The majority (69%, 120/ 174) of early endoleaks were graft-related, which in-lysis as presented in the present report seems justified.
The expected short-and long-term survival rate is the cludes ineffective seal at the attachment sites and leak from the graft itself. 20 Thirty-one percent (54/174) of first and most important information required by the patient. We observed that only persistent endoleaks France; Newcastle, U.K.; Oslo, Norway, Aker Hospital;
Oslo, Norway, Ulleval Hospital; San Sebastian, Spain; were associated with instability (increase of diameter) of aneurysms, and consequently a risk of late rupture. Stockholm, Sweden; Tilburg, The Netherlands, Elisabeth Hospital; Tilburg, The Netherlands, Tweesteden This suggests that freedom-from-persistent endoleak is the second most important variable from the patient's Hospital; Trondheim, Norway; Ulm, Germany; Utrecht, The Netherlands; Veldhoven, The Nether-point of view. Whilst survival and freedom-frompersistent endoleak should be calculated separately, lands; Vienna, Austria; Zü rich, Switzerland. a combined endpoint "persistent endoleak-free survival" gives a realistic and very valuable single measure of outcome. Additional risks of treatment, eurysm size. 27, 29 Future assessment of these different
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